Company Prana Biotechnology Limited Nasdaq
Equities
US7397272045
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 63 | 30/04/17 |
Geoffrey Kempler
FOU | Founder | 69 | 10/11/97 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 30/04/14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Kempler
FOU | Founder | 69 | 10/11/97 |
Peter Marks
BRD | Director/Board Member | 68 | 28/07/05 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 07/08/11 |
Brian Meltzer
BRD | Director/Board Member | 70 | 08/12/99 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,802,360,380 | 2,436,015,074 ( 86.93 %) | 0 | 86.93 % |
Company contact information
Alterity Therapeutics Ltd.
350 Collins Street Level 14
3000, Melbourne
+61 3 9349 4906
http://www.alteritytherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |